Amarin Corp Plc (AMRN)

[marzan]

ok guys lets move on; whatever hell the FDA do with the exclusivity, let them do taking any amount of time, but one thing is sure: generics can't get in now. That's what we wanted and we got it. Otherwise remember the NPE expired in July. So we are in good shape, lets forget about this exclusivity and lets go with the market as it plays out! With 1A marketing already started, we should see increase in scripts exponentially. Also I hope the management might announce some partnership shortly.